Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Zoster Vaccine in Older Adults
NCT00109122Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2001
- Primary completion
- Feb 2003
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 2, randomised, double-blind trial of zoster vaccine, live in herpes zoster (HZ) (2 arms), sponsored by Merck & Co. Primary endpoint: Varicella-Zoster Virus Enzyme-Linked ImmunoSpot Response. Started Nov 2001; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00109122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109122.